CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review

3Citations
Citations of this article
3Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

More powerful prognostic and diagnostic tools are urgently needed for identifying and treating ovarian cancer (OC), which is the most fatal malignancy in women in developed countries. Circular RNAs (circRNAs) are conservative and stable looped molecules that can regulate gene expression by competing with other endogenous microRNA sponges. This discovery provided new insight into novel methods for regulating genes that are involved in many disorders and cancers. This review focuses on the dysregulated expression of circRNAs as well as their diagnostic and prognostic values in OC. We found that studies have identified twenty-one downregulated circRNAs and fifty-seven upregulated ones. The results of these studies confirm that circRNAs might be potent biomarkers with diagnostic, prognostic and therapeutic target value for OC. We also consider the connection between circRNAs and OC cell proliferation, apoptosis, metastasis, and chemotherapy resistance and sensitivity.

Cite

CITATION STYLE

APA

Foruzandeh, Z., Zeinali-Sehrig, F., Nejati, K., Rahmanpour, D., Pashazadeh, F., Seif, F., & Alivand, M. R. (2021, December 1). CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review. Cellular and Molecular Biology Letters. BioMed Central Ltd. https://doi.org/10.1186/s11658-021-00284-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free